Sarine Janetsian-Fritz

Director, Medical + Scientific Strategy at BluPrint Oncology

Sarine Janetsian-Fritz is currently the Director of Medical + Scientific Strategy at BluPrint Oncology. Sarine has a background in neuroscience and psychology, with a Ph.D. in Addiction Neuroscience. Sarine has experience in research and project management in various scientific fields, including oncology, neurology, and addiction studies. Sarine has a strong track record in developing medical and scientific materials, collaborating with key opinion leaders, and supporting the launch of multiple drugs. Sarine is skilled in strategic planning, cross-functional communication, and managing writers to ensure timely completion of projects.

Links